Human Papillomavirus-Related Cancer Surveillance, Prevention, and Screening among Transgender Men and Women: Neglected Populations at High Risk

Brandon Brown, Tonia Poteat, Logan Marg, Jerome T. Galea

Research output: Contribution to journalReview article

Abstract

Researchers and healthcare surveillance systems must clearly disaggregate data for transgender men and women from data for cisgender men and women to identify population-level health disparities and give every person an opportunity for cancer prevention. The limited human papillomavirus (HPV) vaccine recommendations for transgender men and women may be due to the scant literature on cancer prevalence coupled with poor understanding of HPV risks for these populations. Comprehensive cancer screening and prevention initiatives centered on relevant anatomy and sexual risk behaviors that are inclusive of transgender men and women are needed. Moreover, we need specific research to understand the impact of HPV and associated cancers on both transgender men's and women's lives.

Original languageEnglish (US)
Pages (from-to)315-319
Number of pages5
JournalLGBT Health
Volume4
Issue number5
DOIs
StatePublished - Oct 1 2017

Fingerprint

Transgender Persons
Neoplasms
Papillomavirus Vaccines
Risk-Taking
Early Detection of Cancer
Sexual Behavior
Population
Health Status
Anatomy
Research Personnel
Delivery of Health Care
Research

Keywords

  • cancer screening
  • gender identity
  • HPV
  • HPV vaccine
  • prevention
  • transgender

ASJC Scopus subject areas

  • Dermatology
  • Obstetrics and Gynecology
  • Public Health, Environmental and Occupational Health
  • Psychiatry and Mental health
  • Urology

Cite this

Human Papillomavirus-Related Cancer Surveillance, Prevention, and Screening among Transgender Men and Women : Neglected Populations at High Risk. / Brown, Brandon; Poteat, Tonia; Marg, Logan; Galea, Jerome T.

In: LGBT Health, Vol. 4, No. 5, 01.10.2017, p. 315-319.

Research output: Contribution to journalReview article

Brown, Brandon ; Poteat, Tonia ; Marg, Logan ; Galea, Jerome T. / Human Papillomavirus-Related Cancer Surveillance, Prevention, and Screening among Transgender Men and Women : Neglected Populations at High Risk. In: LGBT Health. 2017 ; Vol. 4, No. 5. pp. 315-319.
@article{dab54a2486864d928aa95c657c49a1bf,
title = "Human Papillomavirus-Related Cancer Surveillance, Prevention, and Screening among Transgender Men and Women: Neglected Populations at High Risk",
abstract = "Researchers and healthcare surveillance systems must clearly disaggregate data for transgender men and women from data for cisgender men and women to identify population-level health disparities and give every person an opportunity for cancer prevention. The limited human papillomavirus (HPV) vaccine recommendations for transgender men and women may be due to the scant literature on cancer prevalence coupled with poor understanding of HPV risks for these populations. Comprehensive cancer screening and prevention initiatives centered on relevant anatomy and sexual risk behaviors that are inclusive of transgender men and women are needed. Moreover, we need specific research to understand the impact of HPV and associated cancers on both transgender men's and women's lives.",
keywords = "cancer screening, gender identity, HPV, HPV vaccine, prevention, transgender",
author = "Brandon Brown and Tonia Poteat and Logan Marg and Galea, {Jerome T.}",
year = "2017",
month = "10",
day = "1",
doi = "10.1089/lgbt.2016.0142",
language = "English (US)",
volume = "4",
pages = "315--319",
journal = "LGBT Health",
issn = "2325-8292",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Human Papillomavirus-Related Cancer Surveillance, Prevention, and Screening among Transgender Men and Women

T2 - Neglected Populations at High Risk

AU - Brown, Brandon

AU - Poteat, Tonia

AU - Marg, Logan

AU - Galea, Jerome T.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Researchers and healthcare surveillance systems must clearly disaggregate data for transgender men and women from data for cisgender men and women to identify population-level health disparities and give every person an opportunity for cancer prevention. The limited human papillomavirus (HPV) vaccine recommendations for transgender men and women may be due to the scant literature on cancer prevalence coupled with poor understanding of HPV risks for these populations. Comprehensive cancer screening and prevention initiatives centered on relevant anatomy and sexual risk behaviors that are inclusive of transgender men and women are needed. Moreover, we need specific research to understand the impact of HPV and associated cancers on both transgender men's and women's lives.

AB - Researchers and healthcare surveillance systems must clearly disaggregate data for transgender men and women from data for cisgender men and women to identify population-level health disparities and give every person an opportunity for cancer prevention. The limited human papillomavirus (HPV) vaccine recommendations for transgender men and women may be due to the scant literature on cancer prevalence coupled with poor understanding of HPV risks for these populations. Comprehensive cancer screening and prevention initiatives centered on relevant anatomy and sexual risk behaviors that are inclusive of transgender men and women are needed. Moreover, we need specific research to understand the impact of HPV and associated cancers on both transgender men's and women's lives.

KW - cancer screening

KW - gender identity

KW - HPV

KW - HPV vaccine

KW - prevention

KW - transgender

UR - http://www.scopus.com/inward/record.url?scp=85031295265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031295265&partnerID=8YFLogxK

U2 - 10.1089/lgbt.2016.0142

DO - 10.1089/lgbt.2016.0142

M3 - Review article

C2 - 28876211

AN - SCOPUS:85031295265

VL - 4

SP - 315

EP - 319

JO - LGBT Health

JF - LGBT Health

SN - 2325-8292

IS - 5

ER -